News | Angiography | March 10, 2017

Miniature Particle Accelerator Saves on Contrast Agents for Angiography

X-rays from the MuCLS compact synchrotron at Technical University of Munich open up new possibilities for heart examinations

Technical University of Munich, Munich Compact Light Source, MuCLS, angiography, contrast agents

(a) Photograph of the sample in waterbath. (b) Empty image of full MuCLS beam. (c) Quasi-mono-energetic angiography image of a porcine heart acquired at the MuCLS, with iodine-based contrast agent injected into the left coronary artery. Visible are the left anterior descending artery (LAD) and the left circumflex artery (LCX). Image courtesy of the authors.

March 10, 2017 — The most prevalent method for obtaining images of clogged coronary vessels is coronary angiography. For some patients, however, the contrast agents used in this process can cause health problems. A team at the Technical University of Munich (TUM) has now demonstrated that the required quantity of these substances can be significantly reduced if monoenergetic X-rays from a miniature particle accelerator are used.

Soft tissues such as organs and blood vessels are nearly impossible to examine in X-ray images. To detect a narrowing or other changes in coronary blood vessels, patients are therefore usually injected with an iodinated contrast agent.

These substances can sometimes be hazardous to health, however: "Particularly in patients with kidney insufficiency, complications may arise, in some cases even kidney failure," explained Daniela Münzel, M.D., an adjunct teaching professor for radiology at TUM's Klinikum rechts der Isar. "That is why we are studying possibilities of using lower concentrations of contrast agents."

One approach to reducing the dosage has now been developed by scientists from the Department of Diagnostic and Interventional Radiology at the Klinikum rechts der Isar, working in close cooperation with the Chair of Biomedical Physics at TUM's Department of Physics. The method, which they have described in a paper published in Nature Scientific Reports, is not based on new contrast agents. Instead it relies on special X-rays generated using the Munich Compact Light Source (MuCLS), the world's first mini-synchrotron, which was officially inaugurated at TUM at the end of 2015.

"Conventional X-ray sources generate a relatively broad range of energy levels. By contrast, the energy of X-rays produced by the MuCLS can be controlled much more precisely," said physicist Elena Eggl, the first author of the paper.

Contrast agents such as iodine and gadolinium have an absorption edge. That means that when the substance is exposed to X-rays of a certain energy, the contrast of the final image of the marked organ is particularly good. Below the absorption edge — about 30 kiloelectron volts (keV) for iodine — the contrast deteriorates rapidly. The contrast also becomes weaker at energies far above the absorption edge.

As a result, when using conventional broad-spectrum X-ray sources, an adequate quantity of contrast agent must always be used in order to offset this effect and obtain a sufficiently sharp image for a diagnosis. The MuCLS can generate X-rays that have exactly the optimal energy level. The capability of producing such monoenergetic X-rays has existed for some time. In the past, however, this was possible only with circular particle accelerators with a diameter of several hundred meters. In contrast, the MuCLS is comparable in size to a car.

The data shows that monoenergetic X-rays would make it possible to decrease the required concentration of iodine by about one third with no loss of contrast. For gadolinium, there would even be a somewhat greater reduction. A lot more research is needed, however, before real patients can be examined with monoenergetic X-rays.

"We're still at the very beginning of the development of this technology," said Eggl. The MuCLS is the very first machine of its kind. Moreover, it is designed for fundamental research, and not for examining patients. But with detailed computer simulations and tests with a pig's heart, using blood vessels dyed with iodine, the researchers were able to demonstrate feasibility of the method.

Franz Pfeiffer, professor of biomedical physics at TUM, sees the team's results as a promising start for medical research with the compact synchrotron: "The MuCLS offers numerous possibilities for medical applications that we plan to continue researching with our partners in medical fields,” he said.

The research was funded by the German Research Foundation (DFG), Munich-Centre for Advanced Photonics (MAP) cluster of excellence, the Center for Advanced Laser Applications (CALA), the Ministry for Education and Research, and the DFG Gottfried Wilhelm Leibniz Program.

For more information: www.nature.com/srep

References
Eggl E.,  Mechlem K., Braig E., Kulpe S., et al. "Mono-Energy Coronary Angiography with a Compact Synchrotron Source". Scientific Reports. Published online Feb. 9, 2017. DOI:10.1038/srep42211

Related Content

Toshiba, Aquilion One CT, model-based iterative reconstruction, MBIR, ACC 2017, FIRST, RSNA 2017
News | Computed Tomography (CT) | March 21, 2017
March 21, 2017 — Toshiba Medical demonstrated its Forward projected model-based Iterative Reconstruction SoluTion (FI
Siemens Healthineers, ACC 2017, syngo CTO Guidance, Compressed Sensing Cardiac Cine
News | Cardiac Imaging | March 16, 2017
During the 66th Annual Scientific Session & Expo of the American College of Cardiology (ACC), March 17-19 in...
Siemens Healthineers, Artis pheno angiography system, FDA approval, ACC 2017, RSNA 2017
Technology | Angiography | March 15, 2017
The U.S. Food and Drug Administration (FDA) has cleared the Artis pheno robotic C-arm angiography system from Siemens...
CTA, CT angiography, predict heart attacks, Radiology study
News | CT Angiography (CTA) | March 14, 2017
Noninvasive computed tomography (CT) angiography and stress tests can help predict which patients are likely to suffer...
PRAC, European Medicines Agency, gadolinium-based contrast agents, safety recommendations, brain MRI
News | Contrast Media | March 13, 2017
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recently released new...
Nuclear cardiology, nuclear imaging, radiotracer production, automated radiosynthesis module, myocardial perfusion imaging
Feature | Radiopharmaceuticals and Tracers | March 10, 2017 | Anamika Kumari
Huge portions of the globally produced radiotracers find their origin within geographically centralized, commercial r
calcium scan, CAC score, CT, heart disease screening, prevention, JACC Cardiovascular Imaging study
News | Computed Tomography (CT) | March 08, 2017
Through computed tomography (CT) images of the heart and other types of imaging, build-up of dangerous coronary plaques...
ON Semiconductor, KAF-09001 image sensor, video imaging, digital radiography, angiography, radiographic fluoroscopy, R/F systems
Technology | Radiographic Fluoroscopy (RF) | March 06, 2017
ON Semiconductor announced the release of a new CCD image sensor that enables video imaging under reduced X-ray dosage...
Philips, Azurion platform, angiography, interventional lab, global launch
Technology | Hybrid OR | March 03, 2017
Philips recently announced the global launch of Azurion, its next-generation image-guided therapy platform.
PET imaging, atherosclerotic plaque, inflammation, Ga-68-pentixafor, Technishe Universitat Munchen, Germany

Note the high uptake of Ga-68-pentixafor on multi-planar reconstructions in the organs expressing CXCR4 such as the spleen (red arrows) and adrenal glands (yellow arrows), which was nearly completely blocked by the pre-injection of AMD 3100, a potent CXCR4 inhibitor. Strong accumulation of Ga-68-pentixafor was also found in the kidneys (asterisks) reflecting the renal clearance of the tracer. In addition, high, focal activities were detected in the abdominal aorta (red arrowheads) and right carotid artery (orange arrowheads) of atherosclerotic rabbits, whereas no significant signal could be detected in the non-injured left carotid artery (white arrowheads) of atherosclerotic and control rabbits, as well as in the abdominal aorta and right carotid artery of control rabbits. Furthermore, focal activities detected with PET in atherosclerotic plaques of the abdominal aorta and the right carotid artery decreased significantly when the same rabbit was re-imaged after blocking CXCR4 receptors. Image courtesy of Fabien Hyafil, M.D., Ph.D., Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany

News | PET Imaging | March 03, 2017
March 3, 2017 — In the featured article of the March 2017 issue of...
Overlay Init